CASE REPORT: Long-term Remission of Human Immunodeficiency Virus- associated Visceral Leishmaniasis after Initiation of Potent Combination Antiretroviral Treatment: Report of Two Cases-Reference-Cited by-同舟云学术

CASE REPORT: Long-term Remission of Human Immunodeficiency Virus- associated Visceral Leishmaniasis after Initiation of Potent Combination Antiretroviral Treatment: Report of Two Cases

Published:2000-01 Issue:1 Volume:40 Page:94-96
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Mastroianni C.M.,d’Ettorre G.,Forcina G.,Corpolongo A.,Dell’Isola S.,Lichtner M.,D’Agostino C.,Trinchieri V.,Santopadre P.,Vullo V.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference18 articles.

1. Leishmania and human immunodeficiency virus coinfection: the first 10 years;Alvar;Clin Microbiol Rev,1997

2. Visceral leishmaniasis in patients infected with human immunodeficiency virus;Montalban;J Infect,1990

3. Visceral leishmaniasis in patients infected with the human immunodeficiency virus;Laguna;Eur J Clin Microbiol & Infect Dis,1997

4. Effect of HAART on natural history of AIDS-related opportunistic disorders;Sepkowitz;Lancet,1998

5. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy;Jacobson;AIDS,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases;Tropical Medicine & International Health;2009-06-22

2. The Relationship between Leishmaniasis and AIDS: the Second 10 Years;Clinical Microbiology Reviews;2008-04

3. Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients;Journal of Antimicrobial Chemotherapy;2007-07-10

4. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis;Acta Tropica;2006-08

5. L’amphotéricine B liposomale en prophylaxie secondaire chez les patients VIH+ atteints de leishmaniose viscérale : à propos de cinq cas;Pathologie Biologie;2004-03